VSTM FY 2020 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$388M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89M+407.1% YoY

Gross Profit

$55M61.9% margin

Operating Income

-$49M-55.8% margin

Net Income

-$68M-76.5% margin

EPS (Diluted)

$-5.28

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$154M

Total Liabilities

$39M

Stockholders' Equity

$115M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$17M	+407.1%
Gross Profit	$55M	$15M	+273.9%
Operating Income	-$49M	-$132M	+62.7%
Net Income	-$68M	-$149M	+54.6%